1	planned administration/administration of a vaccine not foresee by the study protocol within 30 day before the first dose of study vaccine s administration of routine meningococcal hepatitis b hepatitis a inactivated influenza and/or poliomyelitis vaccine up to 8 day before the first dose of study|meningococcal[166,179]|||||||||C2960908|1106215|1106215|meningococcal
1	planned administration/administration of a vaccine not foresee by the study protocol within 30 day before the first dose of study vaccine s administration of routine meningococcal hepatitis b hepatitis a inactivated influenza and/or poliomyelitis vaccine up to 8 day before the first dose of study|vaccine[130,137]|||||||30 day[92,98]|||11094|11094|vaccine
1	planned administration/administration of a vaccine not foresee by the study protocol within 30 day before the first dose of study vaccine s administration of routine meningococcal hepatitis b hepatitis a inactivated influenza and/or poliomyelitis vaccine up to 8 day before the first dose of study|poliomyelitis vaccine[233,254]|||||||8 day[261,266]||C0032374|8471|8471|poliovirus vaccines
2	vaccine s be allow enrolment will be defer until the subject be outside of specify window|vaccine[298,305]||||||||||11094|11094|vaccine
